Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Kite, Pfizer enter clinical trial collaboration

Executive Summary

Gilead Sciences Inc.'s Kite Pharma Inc. is teaming up with Pfizer Inc. in a trial collaboration to study the safety and efficacy of Kite's Yescarta (axicabtagene ciloleucel) in combination with Pfizer's utomilumab (PF05082566) for treating patients with refractory large B-cell lymphoma.

Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Immuno-Oncology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Alliance
    • Trial Collaborations
    • R&D (No Licensing)

Related Companies

UsernamePublicRestriction

Register